Login to Your Account



Protecting Blood, Fighting Cancer, in the Liver

Radioprotective Entolimod Broadly Protective in Liver

By Anette Breindl
Science Editor

Monday, May 6, 2013

Researchers have discovered that the TLR5 agonist Entolimod (CBLB502, Cleveland BioLabs Inc.), which is in development as a radioprotective agent, work primarily on receptors in the liver, and that it may be useful to fight liver metastases and, more broadly, as a liver-protective agent.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription